Amyris expands precision fermentation line in Brazil
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Partnership to supercharge LVMH Recherche with Integrated Biosciences’ innovative AI and synthetic biology platform for targeting skin aging
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Subscribe To Our Newsletter & Stay Updated